Masimo Reports Third Quarter 2025 Results

About this update from Masimo Corporation

[{"type":"text","content":" IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter ended September 27, 2025.\n\nThird Quarter 2025 Results From Continuing Operations(1):\n\n\nGAAP revenue of $371.5 million, representing 8.2% growth on a reported basis;\n\n\nNon-GAAP revenue of $371.2 million, representing 7.6% growth on a constant currency basis(2);\n\n\nGAAP net income per diluted share of $0.99; and\n\n\nNon-GAAP net income per diluted share(2) of $1.32, representing 38% growth versus prior year period.\n\n\nKatie Szyman, Chief Executive Officer of Masimo, said, “In the third quarter, we saw continued positive momentum across our core healthcare business, driven by the power of our innovative products. Revenues grew 8%, operating margin improved by 450 basis points, and EPS grew by 38%, all driven by sales growth and our successful operating efficiency initiatives. During the quarter, we closed the sale of Sound United to Harman and used the net proceeds to repurchase common stock. We also announced the expansion of our strategic partnership with Philips. We continue to invest in our core healthcare business to position for strong, sustainable long-term growth, and look forward to sharing more details on our strategy and innovations at our upcoming Investor Day on December 3rd.”\n\n2025 Outlook For Continuing Operations(3):\n\n\nNon-GAAP revenue of $1,510 to 1,530 million, increasing 8.5% to 10.0% on a constant currency basis(2);\n\n\nUpdated guidance excluding the impact of new tariffs:\n\n\nNon-GAAP operating profit of $428 to $440 million;\n\n\nNon-GAAP operating margin of 28.4% to 28.8%; and\n\n\nNon-GAAP earnings per diluted share of $5.62 to $5.79.\n\n\nUpdated guidance including the impact of new tariffs, net of mitigation implemented to date:\n\n\nNon-GAAP operating profit of $412 to $424 million;\n\n\nNon-GAAP operating margin of 27.3% to 27.7%; and\n\n\nNon-GAAP earnings per diluted share of $5.40 to $5.55.\n\n\n\n\n________________\n\n\n\n\n\n(1)\n\n\n\n\nThe financial information reflects the continuing operations of Masimo’s healthcare business.\n\n\n\n\n\n(2)\n\n\n\n\nRepresents a non-GAAP financial measure for which a reconciliation to the most directly comparable GAAP financial measure is included in this earnings release.\n\n\n\n\n\n(3)\n\n\n\n\nRepresents updated...

More updates from Masimo Corporation